Physician profile
Greg T Harmston
NPI 1679549877
$3,888.96
in general payments reported to CMS, 2019-2025
19 companies · $803 in 2025
The $803 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2020: $302 · 2021: $254 · 2022: $524 · 2023: $696 · 2024: $831 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,330.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $973.72 | 2019-2025 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $468.55 | 2019-2024 | Xarelto |
| Amgen INC. | $446.79 | 2019-2025 | Repatha, Otezla, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.56 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $275.10 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $270.87 | 2022-2025 | |
| Novo Nordisk INC | $246.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $237.52 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $193.50 | 2020-2025 | |
| Exact Sciences Corporation | $104.86 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $68.49 | 2022-2023 | |
| Mylan Specialty L.P. | $66.68 | 2022-2024 | Yupelri |
| Xeris Pharmaceuticals, INC. | $47.92 | 2023-2024 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $43.03 | 2019-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.71 | 2021 | |
| Allergan, INC. | $15.60 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.94 | 2022 | |
| Becton, Dickinson and Company | $14.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Harmston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.